Oculus Innovative Sciences, Inc.: Clinical Trials

4 trials sponsored by Oculus Innovative Sciences, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Unknown 1
Phase 41Completed 1

Follow Oculus Innovative Sciences, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pressure Ulcer Healing With Microcyn
Microcyn, Sterile saline - Pressure Ulcer, Spinal Cord Injuries
Phase 4CompletedUniversity of Alabama at Birmingham652013-03-012018-11-06
A Substantial Equivalence Study of RD04723 and Predicate Device
RD047-023, Predicate Device - Hypertrophic Scar, Keloid Scar
Not applicableUnknownOculus Innovative Sciences, Inc.402012-08-012012-12-03
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
RD047-26 - Atopic Dermatitis, Pruritus
Phase 2CompletedOculus Innovative Sciences, Inc.172010-10-012012-05-30
Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections
Topical Dermacyn, Topical Dermacyn and Levofloxacin, Topical Saline and Levofloxacin - Foot Ulcer, Diabetic
Phase 2CompletedOculus Innovative Sciences, Inc.652007-05-012008-01-14

Conditions studied

Cicatrix, Hypertrophic (1)  ·  Dermatitis, Atopic (1)  ·  Diabetic Foot (1)  ·  Infections (1)  ·  Keloid (1)  ·  Pressure Ulcer (1)  ·  Pruritus (1)  ·  Spinal Cord Injuries (1)  ·  Ulcer (1)  ·  Wounds and Injuries (1)

Interventions

Levofloxacin (1)  ·  Preservatives, Pharmaceutical (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  dermacyn (1)

Countries

United States (4)

Top investigators

Andres Gutierrez, M.D., Ph.D. (1)  ·  Janet C DuBois, MD (1)  ·  Yuying Chen, MD, PhD (1)  ·  Zoe Draelos, M.D. (1)